Literature DB >> 11408845

The clinical pharmacology of the oral fluoropyrimidines.

C H Takimoto1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11408845     DOI： 10.1067/mcn.2001.116058

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  2 in total

1.  Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save Lives.

Authors:  Olivier Capitain; Valérie Seegers; Jean-Philippe Metges; Roger Faroux; Claire Stampfli; Marc Ferec; Tamara Matysiak Budnik; Hélène Senellart; Valérie Rossi; Nadège Blouin; Jonathan Dauvé; Mario Campone
Journal:  Dose Response       Date:  2020-09-14       Impact factor: 2.658

2.  DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.

Authors:  Marzia Del Re; Saverio Cinieri; Angela Michelucci; Stefano Salvadori; Fotios Loupakis; Marta Schirripa; Chiara Cremolini; Stefania Crucitta; Cecilia Barbara; Angelo Di Leo; Tiziana Pia Latiano; Filippo Pietrantonio; Samantha Di Donato; Paolo Simi; Alessandro Passardi; Filippo De Braud; Giuseppe Altavilla; Claudio Zamagni; Roberto Bordonaro; Alfredo Butera; Evaristo Maiello; Carmine Pinto; Alfredo Falcone; Valentina Mazzotti; Riccardo Morganti; Romano Danesi
Journal:  Pharmacogenomics J       Date:  2019-02-06       Impact factor: 3.550
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.